AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

56.09 1.69 −2.92%
Market cap
$2.9B
P/E
259×
Fwd P/E
591×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
167.43 122.72 137.29 121.11 119.09 244.22 81.80 124.40 34.45 44.01
Receivables
66.65 60.34 52.50 42.69 33.02 23.15 28.05 25.20 23.08 21.09
Inventory
78.49 75.34 67.90 45.93 38.96 35.03 29.41 22.48 22.45 17.66
Other current assets
— — — — — — — — — 2.95
Total current assets
322.52 267.83 266.25 215.21 196.08 306.74 143.16 174.67 82.26 85.72
Property, Plant, Equpment (Net)
39.12 41.66 42.44 38.83 31.41 28.29 32.65 27.08 28.75 30.00
Long-Term Investments
— — — 51.51 104.34 14.18 12.68 — — 3.00
Goodwill and Intangible Assets (Total)
282.81 291.25 298.77 274.12 277.77 362.98 364.66 154.51 156.02 157.39
Long-term assets (Other)
2.86 2.87 2.16 1.99 0.96 0.44 0.71 0.50 0.68 0.32
Total non-current assets
331.66 341.50 347.69 370.23 419.24 407.80 414.72 182.09 185.45 190.70
Total Assets
654.18 609.33 613.93 585.45 615.31 714.54 557.88 356.76 267.70 276.42
Accounts Payable
25.31 25.03 27.35 19.90 18.60 12.74 14.95 9.66 12.43 10.67
Accrued Expenses
53.09 45.59 44.68 33.02 36.09 27.98 32.75 25.84 18.91 16.47
Current Part of Debt
— — — 5.47 1.76 1.75 2.22 4.72 0.56 1.69
Other current liabilities
3.12 2.81 — 5.47 1.76 8.42 2.22 4.72 0.56 1.69
Total current liabilities
81.52 73.42 74.57 58.39 56.45 49.14 49.92 40.22 31.90 28.83
Long Term Debt (Total)
61.87 61.87 60.59 65.98 69.82 64.40 71.41 47.74 36.86 37.21
Non-current Liabilities (Other)
7.34 1.21 1.23 1.23 1.22 187.42 186.42 19.42 37.77 41.95
Total non-current liabilities
80.72 74.94 73.20 70.30 75.11 253.01 260.62 67.16 74.64 79.15
Total liabilities
162.24 148.36 147.76 128.69 131.56 302.15 310.54 107.38 106.54 107.98
Additional Paid In Capital
904.52 863.71 824.17 787.42 764.81 742.39 529.66 496.54 386.96 367.85
Common Stock (Net)
0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.03
Retained Earnings
(413.20) (401.75) (357.06) (326.62) (280.15) (330.35) (282.20) (247.00) (225.87) (198.97)
Common Equity (Total)
491.94 460.97 466.17 456.75 483.76 412.39 247.34 249.38 161.17 168.44
Shareholders Equity (Total)
491.94 460.97 466.17 456.75 483.76 412.39 247.34 249.38 161.17 168.44
Shareholders Equity and Liabilities (Total)
654.18 609.33 613.93 585.45 615.31 714.54 557.88 356.76 267.70 276.42
Shares (Common)
49.79 48.87 47.53 46.56 46.02 45.35 39.66 38.60 34.59 33.34
Shareholders Equity (Tangible)
209.13 169.72 167.40 182.63 205.98 49.41 (117.32) 94.87 5.15 11.05
Net Debt
(105.56) (60.86) (76.69) (49.66) (47.51) (178.06) (8.17) (71.94) 2.97 (5.12)
Total Debt
61.87 61.87 60.59 71.45 71.58 66.15 73.63 52.46 37.42 38.89

Fold the line items

In millions of $ except per-share values · columns are period end dates